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Abstract The 30 kDa /3-galactoside-binding protein of baby 
hamster kidney (BHK) cells IMehui et al. (1994), J. Biol. Chem. 
269, 18250-18258] homologous to galectin 3, a widely distributed 
mammalian lectin, has been found to be a substrate for tissue type 
transglutaminase, asshown by the incorporation in a calcium- and 
time-dependent manner of 5-(biotinamido) pentylamine in the 
presence of guinea pig liver transglutaminase. The amino-termi- 
nal domain of hamster galectin 3, which is a repetitive sequence 
rich in glutamine, tyrosine, glycine and proline, is also an excel- 
lent substrate. A single lysine residue in the N-terminal domain 
is an essential requirement for transglutaminase-mediated oli-
gomerization, and two equivalent glutamine residues present in 
identical sequence repeats within this domain appear to be in- 
volved as amine acceptors in cross-linking reactions. Transglu- 
taminase-mediated cross-linking of galectin 3 to itself or to ma- 
trix components may be one mechanism for stablisation of a 
muitivalent binding form of the lectin in cell secretions or in 
extracellular matrices. 
domain is a substrate for tissue-type transglutaminase, a cal- 
cium-dependent acyltransferase which catalyses the formation 
of e-(y-glutamyl) ysine isopeptide cross-links between certain 
polypeptides and the conjugation of amines to protein-bound 
glutamine residues [10 12]. 
2. Experimental 
2.1. Materials 
Guinea pig liver transglutaminase [13] was obtained (1.9 Units/mg 
protein) from Sigma Corp. was stored (1.9 units/mg protein, 2Units/ml) 
at -20°C. The biotin-labelled amine, 5-(biotinamido) pentylamine was 
obtained from Pierce Warriner, Chester, UK. Streptavidin horse-radish 
peroxidase was obtained from Vector Laboratories, Peterborough, 
UK. Matrigel, a basement membrane preparation from murine EHS 
tumour, was obtained from Collaborative Research Inc., Bedford, 
MASS, USA. Other reagents unless specified otherwise were purchased 
from Sigma Corp. Synthetic peptides Pepl and Pep2 (Fig. 1) were 
supplied by the Peptide Synthesis facility at N.I.M.R. 
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1. Introduction 
Galectin 3 is a name recently proposed [1] for a family of 
~30-35 kDa fl-galactoside-binding proteins of rat, human, 
mouse and hamster cells that share extensive sequence homol- 
ogies, as well as similar physical properties and carbohydrate- 
binding specificities [2,5]. One striking feature of galectin 3 is 
an N-terminal domain consisting of a repeat sequence of on 
average nine amino acid residues rich in tyrosine, proline, 
glycine and glutamine, the function of which is unknown. Col- 
lagenase-treatment of galectin 3 selectively degrades the N- 
terminal domain leaving a C-terminal fragment that retains full 
carbohydrate-binding activity [5-8]. However, multivalency as 
assessed by haemagglutination r by positive cooperativity of 
lectin binding to multivalent glycoprotein ligands [7-9] requires 
the N-terminal domain. Chemical cross-linking studies indicate 
that the human [7,8] and hamster [5] lectin and the recombinant 
N-terminal domain of the latter [5] can associate to form inter- 
molecular aggregates in a concentration-dependent manner, 
raising the possibility that a switch to multivalency of binding 
may be regulated through self-association of lectin molecules 
mediated mainly through the N-terminal domain. We show 
here that hamster galectin 3 and specifically the N-terminal 
2.2. Recombinant proteins 
Characterization and bacterial expression of a full-length cDNA 
clone (il) of hamster galectin 3, and purification, collagenase treatment 
and N-terminal sequencing of recombinant lectin has been described 
[5]. cDNA corresponding to amino acid residues from 1 to 125 of the 
hamster galectin sequence starting at the initiating methionine and 
ending at Met ~25 was generated by PCR, expressed as a fusion protein 
with glutathione S-transferase and the N-terminal lectin fragment was 
purified by affinity chromatography on a glutathione-based matrix 
followed by thrombin cleavage of the fusion protein [5]. The predicted 
amino acid sequence of the product (Fig. 1) contains ix extra amino 
acids GSPGRP originating from the thrombin cleavage site of the 
fusion protein [5]. The same strategy was used to prepare a mutant 
N-terminal fragment containing a Lys l14--*Ala ~ 14 substitution. Briefly, 
a PCR product was obtained using BioTaq polymerase (Bioline, Lon- 
don, UK), primers 5'-TCCCCGGGTCGACCCATGGCAGACGGT- 
TTTTCGC-3' and 5'-ATGAATTCTTACATTCGAGGCATGACTC- 
CTCCAGCCAAGGGCAGCGCA TA-3' (double underline indicates 
Ala codon) and il cDNA clone as template using the following condi- 
tions: one cycle for 3 min at 94°C, 10 cycles of denaturation at94°C 
lbr 30 s, annealing at 50°C for 1 min, extension at 72°C for 1 rain, 20 
cycles at 94°C for 30 s, 57°C for 1 min, 72°C for 1 rain and finally 
1 cycle at 72°C for 5 rain. The PCR product giving a single 370 bp band 
was subcloned into the pGex-2T plasmid (Pharmacia) using SmaI 
EcoRI restriction sites and used to transform E. coli DH 5~ [5]. A 
positive transformant was picked and the mutated nucleotide sequence 
was verified by dideoxy-chain termination sequencing using internal 
primers as before [5]. This transformant was induced by IPTG, fusion 
protein was identified by Western blotting of bacterial extracts and 
purification of mutant N-terminal fragment was carried out exactly as 
described for wild-type fragment [5]. Fragments were concentrated to
approximately 1 mg/ml using Amicon Centricon 3 membranes (Ami- 
con) and stored at 2°C without freezing. 
*Corresponding author. Fax: (44) (81) 906 4477. 
Abbreviations." BHK, baby hamster kidney; TG, transglutaminase; 
PAGE, polyacrylamide gel electrophoresis; PCR, polymerase chain 
reaction; EHS, Englebreth-Holm-Swarm. 
2.3. Antibodies 
Polyclonal antibodies raised in rabbits against purified BHK cell 
galectin 3 were obtained as described [4,5]. Rabbit antibodies against 
synthetic peptide P2 (Fig. 1) were raised by subcutaneous injection of 
peptide P2 coupled to keyhole limpet haemocyanin in complete 
Freund's adjuvant at five sites. Following six booster injections in 
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incomplete Freund's adjuvant antisera were collected seven days after 
the final boost injection. Goat anti-rabbit mmunoglobulin coupled to 
horse-radish peroxidase was purchased from ICN Biochemicals, Cal., 
USA. 
2.4. SDS-Polyacrylamide g l electrophoresis and blotting 
Electrophoresis u ing 10% or 15% polyacrylamide g ls and antibody 
blotting was carried out as described [14]. Biotinylated proteins were 
detected after electrophoresis by incubation of filters with streptavidin- 
peroxidase conjugate (2/lg/ml in 10 mM HEPES buffer, pH 7.2) at 
room temperature for2 h. Bands were visualized using 3-amino-9-ethyl 
carbazole (Sigma) as substrate. 
2.5. Transglutaminase incubation 
Reaction mixtures containing recombinant protein (10,ul of 0.1 mM 
solutions), 500 mM Tris-HCl, pH 6.8-0.15 M NaCI (15 HI), 0.15 M 
CaC12 (1 HI), 5-(biotinamido) pentylamine (5 H1 of a 10 mM solution) 
or water (5 HI) and guinea pig liver transglutaminase (4/A) were incu- 
bated for various periods at 37°C. In some xperiments synthetic pep- 
tides Pepl or Pep2 (Fig. 1) were added (5 H1 of l0 mM solutions) to 
reaction mixtures. Following incubation, the reaction mixtures were 
mixed with 10/~1 of five-fold strength Laemmli sample buffer containing 
5% l-mercaptoethanol and boiled at 100°C for 5 min before SDS 
polyacrylamide g l electrophoresis. 
2.6. Gel filtration 
A reaction mixture containing recombinant N-terminal fragment 
rCBP-N (100/~1, 0.1 mM solution), 500 mM Tris-HCl, pH 6.8, 150 mM 
NaC1 (150/ll), 150 mM CaClz (10/A), 5-(biotinamido) pentylamine (50 
,ul, 10 mM solution) and guinea pig liver transglutaminase (40/.tl) was 
incubated overnight at 37°C and applied to a column (2 cm x 55 cm) 
of Biogel P60 100--200 mesh (Biorad) equilibrated with 10 mM HEPES 
buffer, pH 7.2, 150 mM NaCI. Fractions (2 ml) were collected at 2°C 
and aliquots (40,ul) were analyzed for protein by the bicinchoninic a id 
(BCA, Pierce) assay. Selected fractions were mixed (1 ml aliquots) with 
Streptavidin Agarose beads (100 H1, 10% suspension i  10 mM HEPES 
buffer pH 7.2, 150 mM NaC1) and incubated at 2°C overnight. The 
beads were washed three times with buffer, suspended in Laemmli 
sample buffer (50 H1) and boiled at 100°C for 5 min. Aliquots (30/tl) 
were subjected toSDS-polyacrylamide gelelectrophoresis followed by 
Streptavidin-peroxidase blotting. In control experiments a sample of 
rCBP-N (100 HI, 0.1 mM solution) was applied to the Biogel P60 
column and analyzed as above. 
3. Results 
Incubation of pure recombinant hamster galectin 3 [5] with 
guinea pig liver transglutaminase (TG) in approximately 20:1 
molar ratio catalyzed the incorporation of5-(biotinamido) pen- 
tylamine into the lectin as detected by reducing SDS-PAGE 
and Western blotting with Streptavidin peroxidase conjugate. 
A single band of Mr = 30,000 expected for hamster galectin 3
[4] was biotinylated in a time-dependent manner (Fig. 2), and 
was dependent on calcium ions since addition of EDTA abol- 
ished the incorporation (result not shown). When a parallel set 
of mixtures but lacking the biotinamine probe was analyzed by 
SDS-PAGE and Western blotting with antibodies raised 
against hamster galectin 3 [4,5] we observed a time-dependent 
appearance of an antibody-reactive Mr = - 60,000 component on 
SDS-PAGE consistent with a dimer (Fig. 2). 
The N-terminal domain of hamster galectin 3[5] contains five 
glutamine residues in a proline-, tyrosine- and glycine-rich re- 
petitive sequence (Fig. 1). When recombinant N-terminal frag- 
ment extending through to residue Met 12s was treated with 
transglutaminase oligomerization occurred as shown by im- 
munoblotting of reaction mixtures with anti-lectin antibodies 
(Fig. 3A). After 1-2 h incubation products up to hexamers 
could readily be detected (Fig. 3A) and longer time (16 h) gave 
higher oligomers that failed to enter the resolving SDS-poly- 
acrylamide gel (result not shown). The incorporation of the 
biotinamine probe into the N-terminal fragment occurred to- 
gether with oligomerization (Fig. 3A). A large-scale incubation 
mixture containing 100/lg of N-terminal fragment plus bioti- 
namine was fractionated after long-term treatment with 
transglutaminase by Biogel P60 chromatography (Fig. 4A). The 
peak protein fractions eluted ahead of those of a control mix- 
ture containing N-terminal fragment not treated with transglu- 
taminase. In the latter case the peak fractions were eluted with 
a ~-lactalbumin standard (M r = 14,200) consistent with an ap- 
parent monomeric size. Column fractions from the transglu- 
taminase-containing reaction mixture, analyzed by SDS- 
PAGE under reducing conditions and blotting with Strep- 
tavidin-peroxidase, howed (Fig. 4B) the fractionation of biot- 
inylated polypeptides of various sizes. The earlier eluting frac- 
tions contained increasing amounts of the most highly cross- 
linked products, the largest of which migrated on SDS-PAGE 
with Mr -- ~75,000 90,000 consistent with their point ofelution 
from Biogel P60 just ahead of a BSA (M r = 64,000) standard. 
Two identical repeats within the N-terminal domain of ham- 
ster galectin 3contain glutamine residues Q47 and Q56 (Fig. 1). 
Peptides containing one (Pepl) or two (Pep2) repeats were 
synthesized and examined for their ability to act as acyl donors 
in transglutaminase-catalyzed reactions. Reaction mixtures 
were set up containing N-terminal fragment, he biotinamine 
probe, transglutaminase nd an excess (about 30-fold) of either 
Pepl or Pep2 and the products formed after incubation at 37°C 
were analyzed by SDS-PAGE and blotting either with Strep- 
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Fig. 1. Amino acid sequence ofrecombinant N-terminal fragment of hamster galectin 3. Residues are numbered from the initial methionine toMet t 25. 
Lys ~ ,4 is boxed. Six additional residues underlined atthe N-terminal derive from the thrombin cleavage site of the fusion protein (see Ref. 5 for details). 
Synthetic peptides Pep 1 (residues 44-52) and Pep2 (residues 44-70) are underlined. The N-termini of carbohydrate-binding fra ments generated by 
digestion of galectin 3with bacterial collagenase (v) and by endogenous proteolysis (v) are indicated. 
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Fig. 2. Transglutaminase catalyzed cross-linking ofhamster galectin 3. 
Equal amounts of hamster galectin 3were incubated with TG with (left 
hand panel) or without (right hand panel) a biotinamine probe for the 
times indicated. After reducing SDS 15% PAGE the separated prod- 
ucts were blotted with either Streptavidin-peroxidase or with anti- 
galectin 3serum followed by second antibody-peroxidase. Monomeric 
(open arrow heads) and dimeric (filled arrow head) galectin 3 are 
indicated. The migration of protein standards i  indicated at left hand 
margin. 
tavidin or with antibodies raised against Pep2. This antibody 
reacted with whole galectin and the N-terminal fragment in 
immunoblotting after SDS-PAGE and the specific reactions 
were blocked by 200/.tg/ml of Pep2 (Fig. 5). Minor cross reac- 
tions with unidentified polypeptides in both recombinant ga- 
lectin 3 and N-terminal fragemnt were not blocked. In the 
transglutaminase reaction mixture containing Pep2 a major 
biotinylated band strongly reactive with anti-Pep2 antibodies 
was detected migrating more slowly than the biotinylated mon- 
omeric species (Fig. 3). This band was absent in control mixture 
lacking Pep2. The difference in migration of the biotinylated 
monomer and the new band (about 2,000-3,000) is consistent 
with the expected size of a cross-linked conjugate of N-terminal 
fragment (Mr = 13,000) and Pep2 (M r = 2,500). In the Pepl- 
containing mixture a closely spaced doublet representing the 
biotinylated monomeric species appeared after immunoblot- 
ting (Fig. 3C) suggesting that Pepl containing only 9 amino 
acid residues was also conjugated with the N-terminal fragment 
by transglutaminase. Interestingly although the extent of cross- 
linking appeared to be rather similar in control or peptide- 
containing reaction mixtures as detected by the biotinylation 
probe Streptavidin, reactivity of the cross-linked products, par- 
ticularly trimers and pentramers, to the anti-Pep2 antibodies 
was considerably enhanced in the mixture containing Pep2 
(Fig. 3C, compare tracks 1 and 3). Presumably, oligomers con- 
taining the synthetic peptide react more strongly with the anti- 
bodies than the corresponding oligomers containing only the 
N-terminal fragment. The reason for the apparently weak in- 
corporation of Pep2 into dimers and tetramers (Fig. 3C, track 
1) remains to be determined. 
We considered next the nature of the acyl acceptor in the 
N-terminal fragment, which in proteins or polypeptides is most 
commonly the e-amino group of lysine. The N-terminal frag- 
ment contains just one lysine residue K 114 (Fig. 1) as deduced 
from the eDNA sequence [5]. In order to confirm this assign- 
ment in the protein we took advantage of the susceptibility of
the N-terminal domain of galectin 3 to bacterial Arthrobacter 
iophagus collagenase [5]. N-terminal amino acid sequencing of
the carbohydrate-binding fra ment obtained after collagenase 
treatment by affinity chromatography on asialofetuin gave an 
unambiguous sequence starting at Gly '°3 and ending at Argl24: 
Lys TM was clearly identified in this sequence (result not shown). 
Similar analysis of a carbohydrate-binding fra ment obtained 
by affinity chromatography after endogenous degradation of 
galectin 3 isolated from BHK cells [5] gave an unambiguous 
amino acid sequence starting at Ala TM and ending at Met 122 and 
again giving a clear Lys signal at position 114 (result not 
shown). To determine whether this residue acts as an acyl 
acceptor, a site-directed mutant was made in which the lysine 
was replaced by an alanine. The mutant Kll4---)A 114 fragment 
incorporated the biotinamine probe to comparable extent as the 
normal K j ~4 fragment (Fig. 3B) showing that the glutamine acyl 
donors were functional. However, transglutaminase-catalyzed 
cross-linking of the K ~14----)A114 mutant was blocked (Fig. 3B). 
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Fig, 3. Transglutaminase-catalyzed cross-linking of N-terminal frag- 
ment of hamster galectin 3. (A) Equal amounts of fragment were incu- 
bated at 37°C with TG minus (left hand panel) or plus (right hand 
panel) a biotinamine probe for the times hown and after reducing 
SDS 15% PAGE the separated products were blotted with anti-ham- 
ster galectin 3 serum or with Streptavidin. The migration of protein 
standards are shown at margin. The position ofmonomeric N-terminal 
fragment is indicated by the open arrow head. Oligomeric species are 
indicated by filled arrow heads. (B) Equal amounts of normal Lys TM 
fragment or mutant Ala TM fragment were treated for 5 h at 37°C with 
TG in presence ofbiotinamine and analyzed as in panel A. (C) Equal 
amounts of normal Lys TM fragment were mixed with an excess of 
synthetic peptide Pepl (tracks 2 and 5) or Pep2 (tracks 1 and 4) or no 
synthetic peptide (tracks 3 and 6) and incubated with TG and biotinam- 
ine for 5 h at 37°C before SDS-15% PAGE and blotting with anti-Pep2 
antiserum (tracks 1-3) or with Streptavidin (tracks 4q5). Open arrow 
heads, galectin fragment monomer; filled arrow heads, galectin frag- 
ment oligomers. Conjugates containing Pep2 are shown by double 
arrow heads. 
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Fig. 4, Gel filtration of transglutaminase products. (A) Gel filtration of the N-terminal fragment of hamster galectin 3 before (broken line) and after 
(solid line) transglutaminase-catalyzed cross-linking in presence of biotinamine. The elution of BSA (64 kDa), fl-lactoglobin (36 kDa), ~-lactalbumin 
(14.2 kDa), cytochrome c (12.4 kDa) and synthetic peptide Pep2 (2.5 kDa) are shown (arrows 1-5 respectively). (B) SDS-15% PAGE of selected 
column fractions (22-30) from gel filtration chromatography followed by blotting with Streptavidin. The migration of monomeric, dimeric and 
trimeric species are indicated by arrow heads. 
4. Discussion 
Tissue-type transglutaminase i  widely distributed in most 
cell types as a monomeric M r = 77,000 protein which is pre- 
dominantly cytoplasmic although it can be expressed at the cell 
surface [15-19] to initiate extracellular functions, one of which 
is believed to be stabilization of cell interactions with matrix 
[20,21]. Tissue transglutaminase has a rather selective affinity 
for the glutamine residues in proteins that can act as acyl 
donors in cross-linking reactions [11]. By contrast he nature 
of the primary amine which functions as acyl acceptor is less 
restrictive, and the probe 5'-(biotinamido) pentylamine has 
been used previously as a specific reagent to detect ransglutam- 
inase substrates inwhole cells [22]. Our data shows that galectin 
3 joins a relatively short list of proteins containing lutamine 
residues functional as acyl donors in tissue transglutaminase- 
catalyzed reactions, including cytoskeletal nd plasma mem- 
brane proteins uch as actin [23], lens crystallins [24], lipocortin 
[25] and extracellular matrix proteins uch as fibrinogen [26], 
fibronectin [27], collagen [28,29], nidogen [29] and osteopontin 
[30,31]. 
The finding that transglutaminase catalyzed the limited for- 
mation of hamster galectin 3dimers (Fig. 2A) shows that inter- 
molecular cross-links are produced between the reactive glu- 
tamine residues and available primary amine groups in the 
polypeptide. Some evidence for disulphide-bonded dimeriza- 
tion of mouse [32,33] and human [8] galectin 3, which appeared 
to be reversible and dependent on lectin concentration, has 
been reported. Clearly the Mr = -60,000 component we observe 
(Fig. 2A) in transglutaminase-treated hamster galectin 3 is not 
related to the disulphide-bonded dimers reported by others, 
inasmuch as it persisted after heating with reducing agent and 
SDS-polyacrylamide g l electrophoresis carried out under re- 
ducing conditions. Interestingly, samples of murine galectin 3 
purified by affinity chromatography of mouse lung extracts on 
asialofetuin Sepharose were shown after SDS-PAGE under 
reducing conditions to contain in addition to the expected mon- 
omeric Mr -- 35,000 lectin a minor component of Mr = - 60,000- 
70,000 [34]. Since this latter band clearly had carbohydrate- 
binding activity and reacted with an antibody against he pure 
Mr = 35,000 mouse galectin 3, it is a related molecule formed 
by cross-linking other than a disulphide bond. Such oligomeri- 
zation would lead to multivalency of carbohydrate-binding ac- 
tivity and allow the lectin to form interconnections between 
reactive glycoproteins, to bridge between cells in agglutination 
reactions or possibly to mediate cell-matrix interactions, under 
conditions where monomeric lectin is ineffective or less effec- 
tive for example at low concentrations of lectin. 
The very efficient ransglutaminase-catalyzed cross-linking 
of the hamster N-terminal fragment may be due to its unusual 
amino acid composition containing a high content of proline 
and glycine residues and which exists largely unstructured as 
shown by CD and tryptophan fluorescence spectroscopy [5]. 
The glutamine residues utilized by transglutaminase in other 
proteins are often also found in terminal polypeptide domains 
which are flexible and solvent accessible [35,36]. It seems very 
likely that one or both of the glutamine residues Q47 and Q56, 
which our present data indicate function as acyl donors in 
cross-linking of the fragment, also are involved in transglutam- 
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Fig. 5. Specificity of peptide antibodies. Rabbit polyclonal antisera 
were raised against synthetic peptide Pep2 (Fig. 1) and used for blotting 
of hamster galectin 3 (tracks 2 and 4) or the recombinant N-terminal 
fragment (tracks 1 and 3) in absence or presence of 200 pg of Pep2 as 
indicated. The migration of the fragment (single arrow head) and intact 
galectin 3 (double arrow heads) are shown. 
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inase-mediated reactions with the whole lectin, given the selec- 
tivity of the enzyme in choice of acyl donor. It is not so clear 
that the lysine residue K TM, functional as an acyl receptor in 
fragment cross-linking, also is important in dimerization of the 
intact lectin. For example, six out of nine lysine residues in 
seminal vesicle protein can be involved in cross-linking [37] 
although more selective use of a particular lysine residue is 
known in c~ B-crystallin [35]. In any event, K TM is SO far unique 
to hamster galectin 3 and is replaced by either asparagine in 
human or aspartic acid in mouse and rat galectin 3 (see [5]). If 
transglutaminase-catalyzed cross-linking of intact galectin 3 is 
a general property across species other lysine residues present 
in the C-terminal, carbohydrate-binding domain of the mole- 
cule must be involved. Interestingly, five out of a maximum of 
nine (in the rat) lysine residues are perfectly conserved in ham- 
ster, mouse, rat and human galectin 3 (see [5]). 
Galectin 3 binds in vitro to laminin of EHS tumour [14] and 
we have recently obtained evidence for its association with 
extracellular matrices uch as Matrigel (unpublished results). It 
is interesting that tissue transglutaminase has also been de- 
tected in the pericellular matrix of several tissues [29,38] raising 
the possibility of transglutaminase-catalyzed cross-linking of 
galectin 3 with other matrix proteins. If this is the case, the 
presence of a carbohydrate-binding activity that is stably incor- 
porated into the biomatrix could have interesting biological 
implications for cellular interactions with matrix. 
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